- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is constructive, supporting the smart-money activity read.
MX
TOR
Week ended 24 Jul 2026
Weekly Investor Report
Methanex Corporation · Basic Materials · Chemicals
Latest close
78.72 CAD
2.6%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 6.1% above the Trend Line and sits at 70.9% of its 52-week range. The latest completed week returned 2.6%, after a 15.6% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 52/100.
Setup score
55
out of 100
Latest Close
78.72 CAD
24 Jul 2026
1W Return
2.6%
latest completed week
4W Return
15.6%
short-term follow-through
12W Return
-9.6%
quarterly tape
Trend Breadth
76.9%
40 of 52 weeks active
Volume Ratio
1.0x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Activity pressure is negative, which weakens the current setup.
- 7 reversal markers appear in the recent smart-money tape.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
2.6%
Latest completed week; four-week move 15.6%.
Indicator stack
42/36
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
52/100
21 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 6.1% above the Trend Line and sits at 70.9% of its 52-week range. The latest completed week returned 2.6%, after a 15.6% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
30 Jan
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.5612-week average 0.81
12-week confirmation
Trend active8/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership9/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.56Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers77 reversal markers
No recent accumulation markers. 7 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 15.6% over four weeks, -9.6% over 12 weeks, and 69.8% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year40
Trend breadth76.9%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.82Latest activity-pressure read.
Pressure change5.0%Four-week change in activity pressure.
Leadership11.81Latest relative-leadership reading.
RS change1519.1%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is neither clearly cheap nor expensive.
Factor week 26 Jul 2026
Financial statements through 31 Mar 2026
Field coverage 91%
Model confidence 87%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength34/100Blend of value, momentum, and quality. Underlying universe rank 67; rank 1 is best.
Value34/100Relative valuation strength. Underlying universe rank 67; rank 1 is best.
Quality22/100Profitability and accounting quality. Underlying universe rank 79; rank 1 is best.
Momentum82/100Medium-term price momentum. Underlying universe rank 19; rank 1 is best.
Growth5/100Revenue and earnings growth. Underlying universe rank 96; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework17/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- 1.7x Market value relative to trailing revenue.
- EV / EBITDA
- 13.0x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 8.0% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 21.7% Gross profit retained from each unit of revenue.
- Operating margin
- 9.2% Operating profit retained from revenue.
- Free-cash-flow margin
- 20.7% Free cash flow generated from revenue.
- Return on invested capital
- 4.6% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- -3.5% Latest one-year revenue growth.
- EPS growth
- -57.6% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- 62.8% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 4/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 1.3% Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 1.3% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 4.2x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment52/100
Weighted news tone is neutral across 21 relevant articles.
3 positive · 16 neutral · 2 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-15.3%Distance below the 52-week high.
13-week volatility6.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
30 Jan
27 Feb
27 Mar
24 Apr
22 May
19 Jun
24 Jul
Weeks higher13 of 2613 weeks finished lower.
Best week+18.1%Week of 27 Mar.
Worst week-10.6%Week of 17 Apr.
Latest week+2.6%Week of 24 Jul.
Shape of recent returns
Strong gains8
Modest gains5
Flat weeks0
Modest losses6
Sharp losses7
Recent vol6.4%13-week weekly-return volatility.
Base vol6.1%52-week weekly-return volatility.
Up/down split28/24Count of positive and negative weeks in the 52-week window.
Average skew5.6% / -4.0%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorCA Basic Materials
4-week rank3 / 100
Group average-2.4%
Trend breadth17.0%
Trend17.0%active weekly trend signals
MD13.0%positive activity pressure
RS31.0%positive relative leadership
Four-week leaders
IndustryCA Chemicals
4-week rank1 / 3
Group average2.5%
Trend breadth33.3%
Trend33.3%active weekly trend signals
MD0.0%positive activity pressure
RS66.7%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape52/100
Trend, activity pressure, participation, and risk combine to a 52/100 tape read.
Indicator analysis50/100Latest 12-week confirmation: trend 8/12, activity pressure 5/12, relative leadership 9/12.
Activity pressure 0.56; 7 reversal markers Factors40/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 61; Small Cap Core rank 40 SVQF17/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 250.0 of 300 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment52/100Weighted news tone is neutral across 21 relevant articles.
Methanex (TSX:MX) Supports Renewed Interest In Value Stocks Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 24 Jul 2026 | 78.72 CAD | 2.6% | 74.18 CAD | 59.75 CAD | -0.82 | 11.81 | 976.7K | Off |
| 17 Jul 2026 | 76.73 CAD | 11.4% | 73.38 CAD | 59.60 CAD | -1.00 | 9.88 | 1.5M | Off |
| 10 Jul 2026 | 68.85 CAD | 5.8% | 72.62 CAD | 59.46 CAD | -1.11 | -1.04 | 1.5M | Off |
| 3 Jul 2026 | 65.09 CAD | -4.4% | 72.11 CAD | 59.36 CAD | -1.00 | -6.04 | 1.1M | Off |
| 26 Jun 2026 | 68.09 CAD | -9.9% | 71.69 CAD | 59.29 CAD | -0.86 | -0.83 | 1.3M | On |
| 19 Jun 2026 | 75.57 CAD | -8.8% | 71.08 CAD | 59.19 CAD | -0.64 | 10.33 | 336.6K | On |
| 12 Jun 2026 | 82.84 CAD | 3.4% | 70.19 CAD | 59.02 CAD | -0.32 | 21.35 | 391.3K | On |
| 5 Jun 2026 | 80.08 CAD | -1.5% | 69.14 CAD | 58.83 CAD | 0.02 | 19.75 | 164.4K | On |
| 29 May 2026 | 81.29 CAD | -1.9% | 68.20 CAD | 58.67 CAD | 0.35 | 21.09 | 989.0K | On |
| 22 May 2026 | 82.83 CAD | -4.8% | 67.32 CAD | 58.51 CAD | 0.76 | 25.25 | 1.1M | On |
| 15 May 2026 | 87.00 CAD | 6.0% | 66.21 CAD | 58.32 CAD | 0.98 | 34.98 | 1.1M | On |
| 8 May 2026 | 82.11 CAD | -5.7% | 64.88 CAD | 58.11 CAD | 0.96 | 27.51 | 1.1M | On |
| 1 May 2026 | 87.07 CAD | 7.2% | 63.81 CAD | 57.93 CAD | 1.24 | 36.88 | 1.5M | On |
| 24 Apr 2026 | 81.22 CAD | 9.8% | 62.69 CAD | 57.73 CAD | 1.37 | 28.67 | 1.3M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.